Clinical Trial Update: A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

The document notes the completion of a clinical trial evaluating insulin delivery using the PaQ device in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PaQ Insulin Delivery System

Snippet

Sponsor: CeQur Corporation | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED